Glutathione S-transferase M1 and T1 polymorphisms and cervical cancer risk: A meta-analysis

Neoplasma

Volumn 58, Issue 4, 2011, Pages 352-359

  Wang, D ^a   Wang, B ^a   Zhai, J X ^b   Liu, D W ^c   Su, G G ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c Institute of Hebei Medical Information   (China)

Author keywords

Cervical cancer; Genetic polymorphism; Glutathione S transferase M1; Glutathione S transferase T1; Meta analysis

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE;

ARTICLE; ASIAN; CANCER RISK; CAUCASIAN; DNA POLYMORPHISM; GENOTYPE; HISTOLOGY; HUMAN; META ANALYSIS (TOPIC); SOUTH AND CENTRAL AMERICA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERUS CARCINOMA; ENZYMOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX TUMOR;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 80051652006     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2011_04_352     Document Type: Article

References (47)

1. PARKIN DM, BRAY F, FERLAY J, PISANI P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108. doi:10.3322/canjclin.55.2.74
2. ZELLER JL, LYNM C, GLASS RM. JAMA patient page. Carcinoma of the cervix. JAMA 2007; 298:2336.
3. BEDFORD S. Cervical cancer: physiology, risk factors, vaccination and treatment. Br J Nurs 2009; 18:80-4.
4. HENGSTLER JG, ARAND M, HERRERO ME, OESCH F. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res 1998; 154:47-85.
5. MCILWAIN CC, TOWNSEND DM, TEW KD. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 2006; 25:1639-48.
6. HAYES JD, FLANAGAN JU, JOWSEY IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005; 45:51-88.
7. ZHOU Q, WANG JT, SHAO SL, MA XC, DING L. Case-control study on risk factors of cervical cancer [in Chinese]. J Shanxi Med Univ 2006; 37:379-81.
8. LIU Y, MA WJ, LIU Q, YANG T, XU SY, et al. Association between genetic polymorphism of GSTM1, CYP2E1 and susceptibility to cervical cancer and its precancerous lessions in Uighur women in Xinjiang[in Chinese]. Prog Obstet Gynecol 2009; 18:840-3.
9. WANG KF, FENG J. Glutathione-S-transferase and p53 polymorphisms in cervical carcinogenesis [in Chinese]. Digest of the World Core Medical Journals: Obstetrics/Gynecology 2005; 1:34.
10. SONG GY, SHAO SL, SONG ZY. Association of single nucleotide polymorphism in glutathione S-transferase with susceptibility to cervical cancer [in Chinese]. Tumour Journal of the World 2006; 5:192-4.
11. YU LF, ZHENG QQ. Cigarette smoking and glutathione S-transferase M1 polymorphism associated with risk for uterine cervical cancer [in Chinese]. Foreign Medical Sciences(Section of Medgeography) 2009; 30:27-8, cover 4.
12. AGODI A, BARCHITTA M, CIPRESSO R, MARZAGALLI R, LA ROSA N, et al. Distribution of p53, GST, and MTHFR polymorphisms and risk of cervical intraepithelial lesions in sicily. Int J Gynecol Cancer 2010; 20:141-6. doi:10.1111/IGC.0b013e3181c20842
13. NISHINO K, SEKINE M, KODAMA S, SUDO N, AOKI Y, et al. Cigarette smoking and glutathione S-transferase M1 polymorphism associated with risk for uterine cervical cancer. J Obstet Gynaecol Res 2008; 34:994-1001.
14. AGORASTOS T, PAPADOPOULOS N, LAMBROPOULOS AF, CHRISAFI S, MIKOS T, et al. Glutathione-S-transferase M1 and T1 and cytochrome P1A1 genetic polymorphisms and susceptibility to cervical intraepithelial neoplasia in Greek women. Eur J Cancer Prev 2007; 16:498-504. doi:10.1097/01.cej.0000243859.99265.92
15. Sierra-Torres CH, ARBOLEDA-MORENO YY, Orejuela-Aristizabal L. Exposure to wood smoke, HPV infection, and genetic susceptibility for cervical neoplasia among women in Colombia. Environ Mol Mutagen 2006; 47:553-61. doi:10.1002/em.20228
16. JOSEPH T, CHACKO P, WESLEY R, JAYAPRAKASH PG, JAMES FV, et al. Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection. Gynecol Oncol 2006; 101:411-7. doi:10.1016/j.ygyno.2005.10.033
17. UEDA M, HUNG YC, TERAI Y, SAITO J, NUNOBIKI O, et al. Glutathione-S-transferase and p53 polymorphisms in cervical carcinogenesis. Gynecol Oncol 2005; 96:736-40. doi:10.1016/j.ygyno.2004.11.005
18. Sierra-Torres CH, AU WW, ARRASTIA CD, Cajas-Salazar N, ROBAZETTI SC, et al. Polymorphisms for chemical metabolizing genes and risk for cervical neoplasia. Environ Mol Mutagen 2003; 41:69-76. doi:10.1002/ em.10132
19. GOODMAN MT, MCDUFFIE K, HERNANDEZ B, Ber-Tram CC, WILKENS LR, et al. CYP1A1, GSTM1, and GSTT1 polymorphisms and the risk of cervical squamous intraepithelial lesions in a multiethnic population. Gynecol Oncol 2001; 81:263-9. doi:10.1006/gyno.2001.6154
20. AU WW. Life style, environmental and genetic susceptibility to cervical cancer. Toxicology 2004; 198:117-20. doi:10.1016/j.tox.2004.01.022
21. AU WW, Sierra-Torres CH, TYRING SK. Acquired and genetic susceptibility to cervical cancer. Mutat Res 2003; 544:361-4. doi:10.1016/j.mrrev.2003.05.001
22. MA CL, LIU Y, LU XM, MA ZH. Associaion between incident of cervical cancer in Uighur women and GSTM1 gene [in Chinese]. Chin J Obstat Gynecol 2009; 44:629-31.
23. SONG GY, SONG ZY, XU JP, SHAO SL. Association of single nucleotide polymorphism in glutathione S-transferase-M1 with susceptibility to cercical cancer in Shanxi Province [in Chinese]. Chin J Cancer Prev Treat 2008; 15:1054-6.
24. ZHOU Q, WANG JT, SHAO SL, MA XC, DING L. The study of the relationship between glutathion S-transferase M1, T1 genotypes and the risk of cervical cancer [in Chinese]. Modern Preventive Medicine 2006; 33:269-71.
25. KIRAN B, KARKUCAK M, OZAN H, YAKUT T, OZERKAN K, et al. GST (GSTM1, GSTT1, and GSTP1) polymorphisms in the genetic susceptibility of Turkish patients to cervical cancer. J Gynecol Oncol 2010; 21:169-73. doi:10.3802/ jgo.2010.21.3.169
26. PALMA S, NOVELLI F, PADUA L, VENUTI A, PRIGNANO G, et al. Interaction between glutathione-S-transferase polymorphisms, smoking habit, and HPV infection in cervical cancer risk. J Cancer Res Clin Oncol 2010; 136:1101-9. doi:10.1007/s00432-009-0757-3
27. Settheetham-Ishida W, YUENYAO P, Kularb-Kaew C, SETTHEETHAM D, ISHIDA T. Glutathione S-transferase (GSTM1 and GSTT1) polymorphisms in cervical cancer in Northeastern Thailand. Asian Pac J Cancer Prev 2009; 10:365-8.
28. DE CARVALHO CR, DA SILVA ID, PEREIRA JS, DE SOUZA NC, FOCCHI GR, et al. Polymorphisms of p53, GSTM1 and GSTT1, and HPV in uterine cervix adenocarcinoma. Eur J Gynaecol Oncol 2008; 29:590-3.
29. SINGH H, SACHAN R, DEVI S, PANDEY SN, MITTAL B. Association of GSTM1, GSTT1, and GSTM3 gene polymorphisms and susceptibility to cervical cancer in a North Indian population. Am J Obstet Gynecol 2008; 198:303 e1-6.
30. SOBTI RC, KAUR S, KAUR P, SINGH J, GUPTA I, et al. Interaction of passive smoking with GST (GSTM1, GSTT1, and GSTP1) genotypes in the risk of cervical cancer in India. Cancer Genet Cytogenet 2006; 166:117-23. doi:10.1016/j.cancergencyto.2005.10.001
31. NIWA Y, HIROSE K, NAKANISHI T, NAWA A, KUZUYA K, et al. Association of the NAD(P)H: quinone oxidoreductase C609T polymorphism and the risk of cervical cancer in Japanese subjects. Gynecol Oncol 2005; 96:423-9. doi:10.1016/j.ygyno.2004.10.015
32. LEE SA, KIM JW, ROH JW, CHOI JY, LEE KM, et al. Genetic polymorphisms of GSTM1, p21, p53 and HPV infection with cervical cancer in Korean women. Gynecol Oncol 2004; 93:14-8. doi:10.1016/j.ygyno.2003.11.045
33. SHARMA A, SHARMA JK, MURTHY NS, MITRA AB. Poly-morphisms at GSTM1 and GSTT1 gene loci and susceptibility to cervical cancer in Indian population. Neoplasma 2004; 51:12-6.
34. KIM JW, LEE CG, PARK YG, KIM KS, KIM IK, et al. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma. Cancer 2000; 88:2082-91. doi:10.1002/(SICI)1097-0142(20000501)88:9<2082::AID-CNCR14>3.0.CO;2-D
35. CHEN C, MADELEINE MM, WEISS NS, DALING JR. Glutathione S-transferase M1 genotypes and the risk of squamous carcinoma of the cervix: a population-based case-control study. Am J Epidemiol 1999; 150:568-72.
36. WARWICK AP, REDMAN CW, JONES PW, FRYER AA, GILFORD J, et al. Progression of cervical intraepithelial neoplasia to cervical cancer: interactions of cytochrome P450 CYP2D6 EM and glutathione s-transferase GSTM1 null genotypes and cigarette smoking. Br J Cancer 1994; 70:704-8. doi:10.1038/bjc.1994.378
37. WARWICK A, SARHANIS P, REDMAN C, PEMBLE S, TAYLOR JB, et al. Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: interactions with GSTM1, CYP2D6 and smoking. Carcinogenesis 1994; 15:2841-5. doi:10.1093/carcin/15.12.2841
38. ECONOMOPOULOS KP, CHOUSSEIN S, VLAHOS NF, SERGENTANIS TN. GSTM1 Polymorphism, GSTT1 Polymorphism, and Cervical Cancer Risk: A Meta-Analysis. Int J Gynecol Cancer 2010; 20:1576-80.
39. STEINHOFF C, FRANKE KH, GOLKA K, THIER R, ROMER HC, et al. Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch Toxicol 2000; 74:521-6.
40. WANG J, JIANG J, ZHAO Y, GAJALAKSHMI V, KURIKI K, et al. Genetic polymorphisms of glutathione S-transferase genes and susceptibility to colorectal cancer: A case-control study in an Indian population. Cancer Epidemiol 2010.
41. Salinas-Sanchez AS, Sanchez-Sanchez F, Donate-Moreno MJ, Rubio-Del-Campo A, Gimenez-Bachs JM, et al. Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer. BJU Int 2010.
42. WANG B, HUANG G, WANG D, LI A, XU Z, et al. Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: Evidence from an updated meta-analysis. J Hepatol 2010; 53:508-18. doi:10.1016/j.jhep.2010.03.026
43. YANG CX, MATSUO K, WANG ZM, TAJIMA K. Phase I/II enzyme gene polymorphisms and esophageal cancer risk: a meta-analysis of the literature. World J Gastroenterol 2005; 11:2531-8.
44. DAHABREH IJ, GIANNOULI S, GOTA V, VOULGARELIS M. GSTT1 and GSTM1 polymorphisms and myelodysplastic syndrome risk: a systematic review and meta-analysis. Int J Cancer 2010; 126:1716-23.
45. ZHUO X, CAI L, XIANG Z, LI Q, ZHANG X. GSTM1 and GSTT1 polymorphisms and nasopharyngeal cancer risk: an evidence-based meta-analysis. J Exp Clin Cancer Res 2009; 28:46. doi:10.1186/1756-9966-28-46
46. MO Z, GAO Y, CAO Y, GAO F, JIAN L. An updating metaanalysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review. Prostate 2009; 69:662-88. doi:10.1002/pros.20907
47. WACHOLDER S, SILVERMAN DT, MCLAUGHLIN JK, MANDEL JS. Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol 1992; 135:1029-41.